Concepedia

Sophie Dimonaco

SD

Statistics

Publications

12

Citations

3.3K

H-Index

12

Active since

2013

Affiliations

Roche (United Kingdom)(Current)

Harvard University

Karolinska Institutet

Massachusetts General Hospital

Southend University Hospital NHS Foundation Trust

Sophie Dimonaco is an author at Roche (United Kingdom) specializing in medicine, clinical trials, and influenza vaccines.

Top concepts

Publications per year

2013–2021

12

Publications

12

Trial of Tocilizumab in Giant-Cell Arteritis

John H. Stone, Katie Tuckwell, Sophie Dimonaco et al. · New England Journal of Medicine · 2017 · 1.3K citations · Full text

Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia

Iván O. Rosas, Norbert Bräu, Michael R. Waters et al. · New England Journal of Medicine · 2021 · 1.1K citations · Full text

Tocilizumab in early progressive rheumatoid arthritis: FUNCTION, a randomised controlled trial

Gerd R Burmester, William F. C. Rigby, Ronald van Vollenhoven et al. · Annals of the Rheumatic Diseases · 2015 · 193 citations · Full text

Tocilizumab in Hospitalized Patients With COVID-19 Pneumonia

Iván O. Rosas, Norbert Bräu, Michael R. Waters et al. · 2020 · 132 citations · Full text

, , +9

Glucocorticoid Dosages and Acute‐Phase Reactant Levels at Giant Cell Arteritis Flare in a Randomized Trial of Tocilizumab

John H. Stone, Katie Tuckwell, Sophie Dimonaco et al. · Arthritis & Rheumatology · 2019 · 107 citations · Full text

1–5 of 12